US FDA approves Arcutis' drug to treat chronic skin disease

Arcutis Biotherapeutics

15/12/2023 22:14

Dec 15 (Reuters) - The U.S. Food and Drug Administration
(FDA) on Friday approved Arcutis Biotherapeutics'  ARQT.O  drug
for treating a skin condition called seborrheic dermatitis in
individuals nine years of age and older.
    
    
    

 (Reporting by Pratik Jain in Bengaluru; Editing by Shailesh
Kuber)
 ((Pratik.Jain@thomsonreuters.com;))